Catus Consult ApS: Financial statements 2022
CVR: 39791633
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Catus Consult ApS (CVR 39791633) has filed annual accounts for 2022. In 2022, the company reported a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2022 report amounted to DKK 40,000. The solvency ratio was 100%.
- Profit/Loss
- DKK 0
- Equity
- DKK 40,000
- Total Assets
- DKK 40,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | - | 0 | 40 t. | - |
| 2021 | - | 0 | 0 | 40 t. | - |
| 2020 | - | 30 t. | 23 t. | 19 t. | - |
Official annual report
Keep an eye on Catus Consult ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Catus Consult ApS has published its annual report for 2021. Gross profit came to DKK 0, and the net result was DKK 0.
About Catus Consult ApS
Catus Consult ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2018. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company was previously named Isanans Pharma ApS and Isanans Pharma IVS. The management consists of Kamilla Rolsted. The company is owned by VAMI Holding ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK 680,675 and a net result of DKK 137,824 compared with DKK -7,234 the year before. Equity in the 2025 report amounted to DKK 181,118.